These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 33503302

  • 1. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
    Sung J, Ahn KT, Cho BR, Lee SY, Kim BJ, Kim DK, Park JI, Lee WS.
    Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
    [Abstract] [Full Text] [Related]

  • 2. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L, Frech-Tamas F, Marrett E, Baser O.
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [Abstract] [Full Text] [Related]

  • 3. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
    Kreutz R, Scholze J, Douros A.
    Curr Vasc Pharmacol; 2018 Jan 26; 16(2):197-203. PubMed ID: 28828980
    [Abstract] [Full Text] [Related]

  • 4. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G, Ong SH, Chen W, Wei ZJ, Kahler KH.
    Curr Med Res Opin; 2015 Dec 26; 31(12):2287-96. PubMed ID: 26397178
    [Abstract] [Full Text] [Related]

  • 5. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
    Chrysant SG.
    Postgrad Med; 2011 Nov 26; 123(6):21-31. PubMed ID: 22104451
    [Abstract] [Full Text] [Related]

  • 6. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S, Melino M, Lee J, Fernandez V, Heyrman R.
    Clin Ther; 2010 Jul 26; 32(7):1252-69. PubMed ID: 20678674
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of the single-pill combination of aliskiren 300 mg/amlodipine 10 mg in hypertensive patients not controlled by olmesartan 40 mg/amlodipine 10 mg.
    Axthelm C, Sieder C, Meister F, Kaiser E.
    Curr Med Res Opin; 2012 Jan 26; 28(1):69-78. PubMed ID: 22117838
    [Abstract] [Full Text] [Related]

  • 8. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Jan 26; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 9. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
    Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G, Noetel A, Randerath O.
    High Blood Press Cardiovasc Prev; 2020 Apr 26; 27(2):157-164. PubMed ID: 32219670
    [Abstract] [Full Text] [Related]

  • 10. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, Amarasekara S, Amarasena N, Billot L, de Silva AP, Fernando M, Guggilla R, Jan S, Jayawardena J, Maulik PK, Mendis S, Mendis S, Munasinghe J, Naik N, Prabhakaran D, Ranasinghe G, Thom S, Tisserra N, Senaratne V, Wijekoon S, Wijeyasingam S, Rodgers A, Patel A, TRIUMPH Study Group.
    JAMA; 2018 Aug 14; 320(6):566-579. PubMed ID: 30120478
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb 14; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

  • 12. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
    Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S.
    J Manag Care Spec Pharm; 2019 Jun 14; 25(6):678-686. PubMed ID: 31134857
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M, Christian Rump L, Ammentorp B, Laeis P.
    Clin Drug Investig; 2012 Oct 01; 32(10):649-64. PubMed ID: 22909147
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
    Bramlage P, Ketelhut R, Fronk EM, Wolf WP, Smolnik R, Zemmrich C, Schmieder RE.
    Clin Drug Investig; 2014 Jun 01; 34(6):403-11. PubMed ID: 24719291
    [Abstract] [Full Text] [Related]

  • 15. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Jun 01; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J, Ulmer HJ, Benduhn H, Klebs S.
    Curr Med Res Opin; 2011 Jan 01; 27(1):131-40. PubMed ID: 21117946
    [Abstract] [Full Text] [Related]

  • 17. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
    Volpe M, de la Sierra A, Kreutz R, Laurent S, Manolis AJ.
    High Blood Press Cardiovasc Prev; 2014 Jun 01; 21(2):137-47. PubMed ID: 24532183
    [Abstract] [Full Text] [Related]

  • 18. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
    Kengne AP, Brière JB, Le Nouveau P, Kodjamanova P, Atanasov P, Kochoedo M, Irfan O, Khan ZM.
    Expert Rev Pharmacoecon Outcomes Res; 2024 Sep 01; 24(7):817-827. PubMed ID: 38088763
    [Abstract] [Full Text] [Related]

  • 19. Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
    Volpe M, de la Sierra A, Ammentorp B, Laeis P.
    Adv Ther; 2014 May 01; 31(5):561-74. PubMed ID: 24760656
    [Abstract] [Full Text] [Related]

  • 20. Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
    Chrysant SG.
    Drugs Today (Barc); 2011 Mar 01; 47(3):197-206. PubMed ID: 21494697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.